LANDRI HARDCASTLE: Open Payments
NPI 1326826629 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,578 in 136 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $953 · 2025 $3,578
Food & beverage: $3,578
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $669 |
| Amgen Inc. | 22 | $567 |
| UCB, Inc. | 16 | $485 |
| Janssen Biotech, Inc. | 7 | $342 |
| Novartis Pharmaceuticals Corporation | 18 | $311 |
| GlaxoSmithKline, LLC. | 7 | $255 |
| Lilly USA, LLC | 6 | $182 |
| AstraZeneca Pharmaceuticals LP | 6 | $162 |
| GENZYME CORPORATION | 1 | $147 |
| Mallinckrodt Hospital Products Inc. | 6 | $135 |
Products named: RINVOQ, Bimzelx, TREMFYA, COSENTYX, BENLYSTA, TALTZ, OTEZLA, EVENITY.
Industry payments across LA — which companies pay providers there.
